Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups

REFERENCES

1. 1.↵
   2. Gillies RJ,
   3. Kinahan PE,
   4. Hricak H

   . Radiomics: images are more than pictures, they are data. Radiology 2016;278:563–77 doi:10.1148/radiol.2015151169 pmid:26579733

   CrossRefPubMed
2. 2.↵
   2. Ellingson BM

   . Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 2015;15:506 doi:10.1007/s11910-014-0506-0 pmid:25410316

   CrossRefPubMed
3. 3.↵
   2. Wen PY,
   3. Macdonald DR,
   4. Reardon DA, et al

   . Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol 2010;28:1963–72 doi:10.1200/JCO.2009.26.3541 pmid:20231676

   Abstract/FREE Full Text
4. 4.↵
   2. Narang S,
   3. Lehrer M,
   4. Yang D, et al

   . Radiomics in glioblastoma: current status, challenges and opportunities. Translational Cancer Research 2016;5:383–97 doi:10.21037/tcr.2016.06.31

   CrossRef
5. 5.↵
   2. Abrol S,
   3. Kotrotsou A,
   4. Salem A

   . Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 2017;26:43–53 doi:10.1097/RMR.0000000000000117 pmid:28079714

   CrossRefPubMed
6. 6.↵
   2. Cui Y,
   3. Tha KK,
   4. Teresaka S, et al

   . Prognostic imaging biomarkers in glioblastoma: development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 2016;278:546–53 doi:10.1148/radiol.2015150358 pmid:26348233

   CrossRefPubMed
7. 7.↵
   2. Pérez-Beteta J,
   3. Molina-García D,
   4. Ortiz-Alhambra JA, et al

   . Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 2018; 288:218–55 doi:10.1148/radiol.201171051 pmid:29924716

   CrossRefPubMed
8. 8.↵
   2. Rathore S,
   3. Akbari H,
   4. Rozycki M, et al

   . Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Sci Rep 2018;8:5087 doi:10.1038/s41598-018-22739-2 pmid:29572492

   CrossRefPubMed
9. 9.↵
   2. Cui Y,
   3. Ren S,
   4. Tha KK, et al

   . Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 2017;27:3583–92 doi:10.1007/s00330-017-4751-x pmid:28168370

   CrossRefPubMed
10. 10.↵
    2. Kickingereder P,
    3. Burth S,
    4. Wick A, et al

    . Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology 2016;280:880–89 doi:10.1148/radiol.2016160845 pmid:27326665

    CrossRefPubMed
11. 11.↵
    2. Lao J,
    3. Chen Y,
    4. Li ZC, et al

    . A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep 2017;7:10353 doi:10.1038/s41598-017-10649-8 pmid:28871110

    CrossRefPubMed
12. 12.↵
    2. Wangaryattawanich P,
    3. Hatami M,
    4. Wang J, et al

    . Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 2015;17:1525–37 doi:10.1093/neuonc/nov117 pmid:26203066

    CrossRefPubMed
13. 13.↵
    2. Ingrisch M,
    3. Schneider MJ,
    4. Nörenberg D, et al

    . Radiomic analysis reveals prognostic information in T1-weighted baseline magnetic resonance imaging in patients with glioblastoma. Invest Radiol 2017;52:360–66 doi:10.1097/RLI.0000000000000349 pmid:28079702

    CrossRefPubMed
14. 14.↵
    2. Lasocki A,
    3. Gaillard F,
    4. Tacey M, et al

    . Multifocal and multicentric glioblastoma: improved characterisation with FLAIR imaging and prognostic implications. J Clin Neurosci 2016;31:92–98 doi:10.1016/j.jocn.2016.02.022 pmid:27343042

    CrossRefPubMed
15. 15.↵
    2. Singh G,
    3. Mehrotra A,
    4. Sardhara J, et al

    . Multiple glioblastomas: are they different from their solitary counterparts? Asian J Neurosurg 2015;10:266–71 doi:10.4103/1793-5482.162685 pmid:26425153

    CrossRefPubMed
16. 16.↵
    2. Showalter TN,
    3. Andrel J,
    4. Andrews DW, et al

    . Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 2007;69:820–24 doi:10.1016/j.ijrobp.2007.03.045 pmid:17499453

    CrossRefPubMed
17. 17.↵
    2. Di Carlo DT,
    3. Cagnazzo F,
    4. Benedetto N, et al

    . Multiple high-grade gliomas: epidemiology, management, and outcome: a systematic review and meta-analysis. Neurosurg Rev 2017 Nov 14. [Epub ahead of print] doi:10.1007/s10143-017-0928-7 pmid:29138949

    CrossRefPubMed
18. 18.↵
    2. Patil CG,
    3. Yi A,
    4. Elramsisy A, et al

    . Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg 2012;117:705–11 doi:10.3171/2012.7.JNS12147 pmid:22920963

    CrossRefPubMed
19. 19.↵
    2. Giannopoulos S,
    3. Kyritsis AP

    . Diagnosis and management of multifocal gliomas. Oncology 2010;79:306–12 doi:10.1159/000323492 pmid:21412017

    CrossRefPubMed
20. 20.↵
    2. Paulsson AK,
    3. Holmes JA,
    4. Peiffer AM, et al

    . Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol 2014;119:429–35 doi:10.1007/s11060-014-1515-1 pmid:24990827

    CrossRefPubMed
21. 21.↵
    2. Pérez-Beteta J,
    3. Martínez-González A,
    4. Molina D, et al

    . Glioblastoma: does the pretreatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol 2017;27:1096–104 doi:10.1007/s00330-016-4453-9 pmid:27329522

    CrossRefPubMed
22. 22.↵
    2. Harrell FE Jr.,
    3. Califf R,
    4. Pryor D, et al

    . Evaluating the yield of medical tests. JAMA 1982;247:2543–46 doi:10.1001/jama.247.18.2543 pmid:7069920

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Hassaneen W,
    3. Levine NB,
    4. Suki D, et al

    . Multiple craniotomies in the management of multifocal and multicentric glioblastoma. J Neurosurg 2011;114:576–84 doi:10.3171/2010.6.JNS091326 pmid:20690813

    CrossRefPubMed
24. 24.↵
    2. Pérez-García VM,
    3. Calvo GF,
    4. Belmonte-Beitia J, et al

    . Bright solitary waves in malignant gliomas. Phys Rev E Stat Nonlin Soft Matter Phys 2011;84:021921 doi:10.1103/PhysRevE.84.021921 pmid:21929033

    CrossRefPubMed
25. 25.↵
    2. Grabowsky MM,
    3. Recinos PF,
    4. Nowacki AS, et al

    . Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 2014;121:1115–23 doi:10.3171/2014.7.JNS132449 pmid:25192475

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Henker C,
    3. Kriesen T,
    4. Glass Ä, et al

    . Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 2017;135:391–402 doi:10.1007/s11060-017-2587-5 pmid:28755324

    CrossRefPubMed
27. 27.↵
    2. Pérez-Beteta J,
    3. Molina-García D,
    4. Martínez-González A, et al

    . Morphological MRI-based features provide pretreatment survival prediction in glioblastoma. Eur Radiol 2018 Oct 15. [Epub ahead of print] doi:10.1007/s00330-018-5758-7 pmid:30324390

    CrossRefPubMed
28. 28.↵
    2. Prior FW,
    3. Clark K,
    4. Commean P, et al

    . TCIA: an information resource to enable open science. Conf Proc IEEE Eng Med Biol Soc 2013;2013:1282–85 doi:10.1109/EMBC.2013.6609742 pmid:24109929

    CrossRefPubMed